Development of Continuous Anti-Solvent/Cooling Crystallization Process using Cascaded Mixed Suspension, Mixed Product Removal Crystallizers

This paper describes a two-stage mixed-suspension, mixed-product removal (MSMPR) continuous crystallization developed for a pharmaceutical intermediate which uses anti-solvent and cooling to generate supersaturation. The results indicate that the stage in which anti-solvent is added has a significant influence on the final crystal properties, while purity and yield were nearly identical. The population balance model was employed to determine growth and nucleation kinetics through parameter estimation. With the incorporation of measured equilibrium distribution coefficients, the model was used to optimize crystal purity and yield of the product with respect to operating temperature and residence time.

[1]  Ahmad Y. Sheikh,et al.  Optimal synthesis of stagewise continuous crystallization process networks , 1998 .

[2]  Sohrab Rohani,et al.  Kinetics Estimation and Single and Multi-Objective Optimization of a Seeded, Anti-Solvent, Isothermal Batch Crystallizer , 2008 .

[3]  Allan S. Myerson,et al.  Continuous Plug Flow Crystallization of Pharmaceutical Compounds , 2010 .

[4]  Q. Yin,et al.  Effect of solution thermodynamics on the purification of two isomorphic steroids by solution crystallization , 2006 .

[5]  D. Ramkrishna,et al.  Transformation of the chord-length distributions to size distributions for nonspherical particles with orientation bias , 2007 .

[6]  Gerry Steele,et al.  Continuous Crystallization of Pharmaceuticals Using a Continuous Oscillatory Baffled Crystallizer , 2009 .

[7]  B. Glennon,et al.  In‐line FBRM Monitoring of Particle Size in Dilute Agitated Suspensions , 1999 .

[8]  Alan G. Jones,et al.  Crystallization process optimization via a revised machine learning methodology , 1997 .

[9]  M. Mazzotti,et al.  Modeling and Experimental Analysis of PSD Measurements through FBRM , 2000 .

[10]  R. Braatz,et al.  Measurement of particle size distribution in suspension polymerization using in situ laser backscattering , 2003 .

[11]  John Garside,et al.  Prediction and measurement of crystal size distributions for size-dependent growth , 1978 .

[12]  Alan Jones.  Crystallization Process Systems , 2002 .

[13]  S. Rohani,et al.  Determination of Particle Size Distribution by Par-Tec® 100: Modeling and Experimental Results , 1998 .

[14]  Marco Mazzotti,et al.  Measurement of particle size and shape by FBRM and in situ microscopy , 2008 .

[15]  Alfons Mersmann,et al.  Design of crystallizers , 1988 .

[16]  Narayan S. Tavare,et al.  Mixing in continuous crystallizers , 1986 .

[17]  T. Leyssens,et al.  Optimization of a crystallization by online FBRM analysis of needle-shaped crystals , 2011 .

[18]  R. Braatz,et al.  Parameter Estimation and Optimization of a Loosely Bound Aggregating Pharmaceutical Crystallization Using in Situ Infrared and Laser Backscattering Measurements , 2004 .

[19]  Nigel N. Clark,et al.  Relationship between bubble size distributions and chord-length distribution in heterogeneously bubbling systems , 1998 .